Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial Deeksha Bhandari2 Dec 2025 10:57 AM ISTThe SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or equal to 27 with a comorbidity)...
Hidden blood molecules found to have powerful anti-aging effects in skin cells: Study Anshika Mishra2 Dec 2025 8:15 AM ISTScientists have discovered promising anti-aging compounds produced by a little-known blood bacterium, opening a new frontier for skin rejuvenation....
Alternate-day fasting helps fat loss, may cut muscle too, Study Finds Anshika Mishra1 Dec 2025 8:15 AM ISTAlternate-day fasting promises quick fat loss, but does it secretly steal your hard-earned muscle too? A new study in Nutrients tested four weeks of...
Ramiven: The only CDK4/6i that Delivers Proven and Deepening Protection After a 2-year Treatment Period Dr. Garima Soni28 Nov 2025 12:15 PM ISTIn the video, Dr. Carlos Barrios, director and principal investigator of the Oncology Research Center at Hospital São Lucas and president of the...
Research reveals people with this blood type may have a higher fatal liver disease risk Anshika Mishra28 Nov 2025 8:15 AM ISTYour blood type may reveal more than just transfusion compatibility-it could signal your risk for certain liver diseases. A new study published in...
Study Reveals Mid-Life Exercise Cuts Dementia Risk Nearly Half Anshika Mishra27 Nov 2025 8:30 AM ISTWant to protect your brain from dementia? Start Exercising. A compelling new study from Boston University reveals that staying physically active...
New Study Finds Current Heart Attack Screening Tools Miss 45 Percent of People at Risk Anshika Mishra26 Nov 2025 8:30 AM ISTA recent study led by researchers at Mount Sinai has revealed a critical issue with the current cardiac screening methods used to prevent heart...
PRIME-Vilda Trial Results Highlights Vildagliptin SR's Efficacy and Safety in Indian Type 2 Diabetes Patients on Metformin Deeksha Bhandari25 Nov 2025 12:40 PM ISTThe study evaluates the efficacy and safety of once-daily Vildagliptin SR 100 mg vs Sitagliptin 100 mg in type 2 diabetes patients inadequately...
Real-World Evidence in Psoriatic Arthritis: PRO-SPIRIT Study Dr. Garima Soni25 Nov 2025 11:45 AM ISTIn the video, Dr. Nicola J. Gullick, a Consultant Rheumatologist in Coventry and one of the investigators on the PRO-SPIRIT study, provides an...
Andhra University team discovers spike protein change impacting Covid vaccine efficacy Anshika Mishra25 Nov 2025 8:00 AM ISTA recent study by researchers at Andhra University has uncovered a clever way the Coronavirus might be dodging the antibodies created by COVID-19...
CRISPR breakthrough disables gene, reverses resistant lung cancer growth: Study Anshika Mishra24 Nov 2025 8:30 AM ISTA revolutionary breakthrough in cancer therapy could transform the treatment landscape for resistant lung tumors. Researchers at Christiana Care's...
New antibody breakthrough offers hope to slow polycystic kidney disease progression Anshika Mishra24 Nov 2025 8:15 AM ISTA new frontier in treating polycystic kidney disease (PKD) has emerged from the labs at the University of California, Santa Barbara. Led by biologist...
